Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
19 publications from 2016
Usher, C., Adams, R., Schmitz, S., Kieran, J., O'Flanagan, D., O'Donnell, J., Connolly, K., Corcoran, B., Butler, K., Barry, M., Walsh, C., Evaluating the neonatal BCG vaccination programme in Ireland, Archives of Public Health, 74, (1), 2016
Sandys, V., Barry, M., The use of aspirin in primary prevention of cardiovascular disease, Irish Medical Journal, 109, (3), 2016, p368
Fogarty, E., Schmitz, S., Tubridy, N., Walsh, C., Barry, M., Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis, Multiple Sclerosis and Related Disorders, 9, 2016, p23-30
British Pharmacological Society E Journal(ed.), Simvastatin reduces IL-1β secretion from PBMCs when treated with cholesterol crystals., , 2016
Roulston GD and Burt CL and Kettyle LM and Matchett KB and Keenan HL and Mulgrew NM and Ramsey JM and Dougan C and McKiernan J and Grishagin IV and Mills KI and Thompson A, Low-dose salinomycin induces anti-leukemic responses in AML and MLL., Oncotarget, 2016
Gangadharan N, Kavanagh P , Walsh PT1, Hemeryck L, Kieran J, Barry M, Lucitt M. , Simvastatin reduces IL-1β secretion from PBMCs when treated with cholesterol crystals., British Pharmacology Society Annual Meeting London Dec 2016, London UK, 2016
Casey, G. and Ward, M. and Spiers, J.P. , The role of PP2A and related proteins in Human Brain Microvascular Endothelial Cells in response to Pro and Anti-Inflammatory Cytokines, pA2 online, Pharmacology 16, London, British Pharmacology Society, 2016, pp176P
Harkin, K. and Metcalfe, A. and Harbinson, M. and Campbell, M. and Spiers, J.P. and Bell, D., Influence of intermedin/adrenomedullin-2 on nephrotoxic drug-related injury to human renal mesangial and tubular epithelial cells, pA2 online, Pharmacology 2016, London, British Pharmacological Society, 2016, pp222P
Dolan E, Schmitz S, Barry M, McCullagh L, Movement of Drugs for Cancer Through The Pharmacoeconomic Evaluation Process in Ireland: Consideration Given to The Quality of Clinical Evidence, Value Health, 2016, 19, (7), 2016, ppA757 - A757
O'Donnell H, McCullagh L, Barry M, The Potential Budget Impact of PCSK9 Inhibitors in Ireland, Value Health, 2016, 7, (19), 2016, ppA643 - A643
Gorry C, McCullagh M, Barry M, Drug Utilisation of Braf Inhibitors for Melanoma in Ireland, Value Health, 19, (7), 2016, ppA728 - A728
Schmitz S, McCullagh L, Dolan E, Walsh C, The Quev Score: A Quantitative Evaluation of the Quality of Clinical Evidence in HTA, Value Health, 19, (7), 2016, ppA499 - A499
Spillane S, McCullagh L, Barry M, Usher C, Analysis of Pharmacy Claims for High Cost Oncology Products: Abiraterone and Enzalutamide Usage in Mcrpc in Ireland, Value Health, 19, (7), 2016, ppA754 - A754
Ermisch M, Bucsics A, Vella Bonanno P, Arickx F, Bybau A, Bochenek T, van de Casteele M, Diogene E, Fürst J, Garuolien" K, van der Graaff M, Gulbinovi" J, Haycox A, Jones J, Joppi R, Laius O, Langner I, Martin AP, Markovic-Pekovic V, McCullagh L, Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways., 2016
Morgan RB, McCullagh L, Barry M, Daly C, The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting., 2016
Miller, A.M., Begley, E., Coen, R.F., Doyle, M., Dunne, J., Hutchinson, S., Kennelly, S.P., Kenny, R.A., Killeen, R.P., O'Dwyer, S., O'Neill, C., O'Sullivan, S.S., Rowan, M.J., Sheehy, N., McGuigan, C., Lawlor, B.A. , Clinical consensus guidelines on the application of cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: recommendations of the Irish Network for Biomarkers in Neurodegeneration., Irish Medical Journal, 109, (10), 2016, p1-13
Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM., Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria., European Journal of Clinical Pharmacology, 72, (5), 2016, p583 - 591
McCullagh L, Barry M, The Pharmacoeconomic Evaluation Process in Ireland, PharmacoEconomics, 34, (12), 2016, p1267 - 1276
Schmitz S, McCullagh L, Adams R, Walsh C, Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland, PharmacoEconomics, 2016